GlassScriptPhysician profile
Adam Provost
NPI 1497486260
$1,486.79
in general payments reported to CMS, 2019-2025
15 companies · $1,087 in 2025
The $1,087 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $51.42 · 2024: $348 · 2025: $1,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,435.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $395.62 | 2024-2025 | Xdemvy |
| Mallinckrodt Hospital Products INC. | $296.74 | 2024-2025 | Acthar |
| Abbvie INC. | $180.45 | 2024-2025 | |
| Dompe US, INC. | $114.53 | 2024-2025 | Oxervate |
| Genentech USA, INC. | $94.26 | 2024-2025 | Vabysmo |
| Bausch & Lomb Americas INC. | $74.67 | 2025 | Miebo, Envista Envy Iol, Infuse |
| Harrow Eye, LLC | $69.15 | 2024 | Flarex |
| Astellas Pharma US INC | $62.91 | 2025 | Izervay |
| Sun Pharmaceutical Industries INC. | $60.53 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $34.08 | 2024 | Eylea Hd |
| Carl Zeiss Meditec, INC. | $33.00 | 2022 | |
| Ani Pharmaceuticals, INC. | $22.33 | 2025 | Purified Cortrophin Gel |
| Heidelberg Engineering, INC. | $18.42 | 2022 | |
| Alcon Vision LLC | $15.23 | 2025 | Rocklatan |
| Coopervision INC. | $14.87 | 2025 | Myday Contact Lens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Provost listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.